脓毒症患者中度血糖控制下血糖异常的 Incidence 与影响
该研究为前瞻性多中心 FORECAST 研究脓毒症队列的预设亚组分析,纳入 1,140 例严重脓毒症患者(含 259 例既往糖尿病)。血糖中位数在 0 h 和 72 h 约 140 mg/dL,提示中度控制。初始高血糖率 27.3%,晚期高血糖率 21.7%,初始 24 h 内早期低血糖发生率 13.2%。在非糖尿病患者中,晚期高血糖(HR 1.816,95%CI 1.116-2.955,P=0.016)和早期低血糖(HR 1.936,95%CI 1.180-3.175,P=0.009)与院内死亡正相关;糖尿病患者未观察到这些相关性。
要点
- 严重脓毒症患者在中度血糖控制下,初始高血糖率 27.3%、晚期高血糖率 21.7%,初始 24 h 内早期低血糖发生率 13.2%。
- 非糖尿病患者中,晚期高血糖与院内死亡正相关(HR 1.816,95%CI 1.116-2.955,P=0.016)。
- 非糖尿病患者中,早期低血糖发作与院内死亡正相关(HR 1.936,95%CI 1.180-3.175,P=0.009)。
- 亚组分析提示晚期高血糖与早期低血糖独立、且可能协同影响结局。
- 糖尿病患者中未观察到上述相关性。
适用人群与场景
- 严重脓毒症患者,共 1,140 例,其中 259 例为既往糖尿病患者。
研究设计与关键结果
- 研究类型:前瞻性、多中心 FORECAST 研究脓毒症队列的预设亚组分析。
- 共纳入 1,140 例严重脓毒症患者,包括 259 例既往糖尿病者。
- 0 h 和 72 h 血糖中位数约 140 mg/dL,提示血糖为中度控制。
- 初始高血糖率 27.3%,晚期高血糖率 21.7%,初始 24 h 内早期低血糖发生率 13.2%。
- 血糖控制伴随初始和晚期高血糖比例更高,但不伴随早期低血糖发作,提示血糖控制针对过度高血糖。
- 非糖尿病患者:晚期高血糖与院内死亡正相关(HR 1.816,95%CI 1.116-2.955,P=0.016);早期低血糖发作与院内死亡正相关(HR 1.936,95%CI 1.180-3.175,P=0.009)。
- 亚组分析提示晚期高血糖和早期低血糖独立、且可能协同影响结局。
- 糖尿病患者中未观察到这些相关性。
证据类型、等级与局限
- 证据类型:前瞻性、多中心队列研究的预设亚组分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,需要更精细的方法来降低这些严重并发症的发生率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Glycemic control strategies for sepsis have changed significantly over the last decade, but their impact on dysglycemia and its associated outcomes has been poorly understood. In addition, there is controversy regarding the detrimental effects of hyperglycemia in sepsis. To evaluate the incidence and risks of dysglycemia under current strategy, we conducted a preplanned subanalysis of the sepsis cohort in a prospective, multicenter FORECAST study. A total of 1,140 patients with severe sepsis, including 259 patients with pre-existing diabetes, were included. Median blood glucose levels were approximately 140 mg/dL at 0 and 72 h indicating that blood glucose was moderately controlled. The rate of initial and late hyperglycemia was 27.3% and 21.7%, respectively. The rate of early hypoglycemic episodes during the initial 24 h was 13.2%. Glycemic control was accompanied by a higher percentage of initial and late hyperglycemia but not with early hypoglycemic episodes, suggesting that glycemic control was targeted at excess hyperglycemia. In nondiabetic patients, late hyperglycemia (hazard ratio, 95% confidence interval; P value: 1.816, 1.116-2.955, 0.016) and early hypoglycemic episodes (1.936, 1.180-3.175, 0.009) were positively associated with in-hospital mortality. Further subgroup analysis suggested that late hyperglycemia and early hypoglycemic episodes independently, and probably synergistically, affect the outcomes. In diabetic patients, however, these correlations were not observed. In conclusion, a significantly high incidence of dysglycemia was observed in our sepsis cohort under moderate glycemic control. Late hyperglycemia in addition to early hypoglycemia was associated with poor outcomes at least in nondiabetic patients. More sophisticated approaches are necessary to reduce the incidence of these serious complications.
参考来源
- Fujishima S, Gando S, Saitoh D, et al. Incidence and Impact of Dysglycemia in Patients with Sepsis Under Moderate Glycemic Control. Shock. 2021. PMID: 33978606. doi:10.1097/SHK.0000000000001794
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。